New research suggests that individuals who come off popular weight-loss injections like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who stop traditional lifestyle programs.
Published data in a major health publication demonstrates that while obese individuals can lose a large proportion of their body weight while on the medication, the mass is regained at an average rate of nearly a kilo each month after stopping.
"People purchasing these treatments must be informed of the risk of fast rebound weight gain when the treatment concludes," stated researcher Dr. Susan Jebb.
That rate of regain implies a return to pre-treatment weight within about a year and a half.
Weighing Therapies
The research, which reviewed 37 of studies involving over 9,000 of patients, contrasted the outcomes of these new drugs with older methods.
Researchers point out that people who shed pounds through lifestyle changes alone generally have a slower weight regain—approximately 100 grams monthly—post-intervention.
The Reason for the Rapid Regain
Doctors propose the mode of action of the injections explains the accelerated rebound.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing the hormone levels far above than normal could lead to the system to produce less of its own natural GLP-1, and may also diminish responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.
"Stopping of this hormone supplement results in hunger is uncontrolled, making overeating a significant risk."
A Chronic Condition?
Health authorities advise the injections for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Professionals say that, considering the high risk of weight regain, the treatment should be considered ongoing.
This opinion is supported by drug manufacturers, who state that the findings "underscore the persistent nature of obesity," comparing it to managing diseases like high blood pressure.
User Testimonies
Users who have stopped the medication report a powerful return of cravings.
"It felt as if a trigger flipping and you become ravenous," described an individual.
This difficulty is compounded if individuals have not established permanent lifestyle or habit changes during treatment.
Significant Adoption
Survey data indicate that millions of adults in the UK have tried these injections in the last 12 months, with demand remaining high.
- Use is more common among women compared to men.
- The middle-aged age group shows the highest level of interest.
- Many obtain the medications through private healthcare rather than the NHS.
Ultimately, clinicians stress that while the jabs are potent tools for weight loss, they are not a magic fix and maintained weight loss likely depends on ongoing lifestyle management.